trending Market Intelligence /marketintelligence/en/news-insights/trending/uWWXRcEB14HFoxmZJ6ov4A2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Lilly to invest more than $470M in new North Carolina manufacturing plant

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Lilly to invest more than $470M in new North Carolina manufacturing plant

North Carolina Gov. Roy Cooper said Eli Lilly and Co. will invest more than $470 million in a new pharmaceutical manufacturing facility in the state, which will create more than 460 jobs.

The new manufacturing site in Durham County will produce parenteral products and delivery devices. Lilly will hire personnel, including scientists, engineers and quality professionals, to operate the site.

Lilly's Chairman and CEO David Ricks said the pharmaceutical giant has invested "billions of capital" in new manufacturing units in the U.S. since the 2017 tax reforms that "rebalanced the playing field in favor of the American worker."

The project in North Carolina will be facilitated, in part, by a job development investment grant approved by the state's Economic Investment Committee. Lilly will be entitled to a tax reimbursement of up to $8.7 million over the 12-year term of this grant.

State payments only occur after performance verification by the departments of commerce and revenue that the company has met its incremental job creation and investment targets.